Kaukasisk etnicitet var forbundet med lavere behandlingsrespons for begge antivirale midler anvendt i GLOBE undersøgelsen; den kaukasiske patientpopulation var dog meget begrænset (n = 98).
Caucasian ethnicity was associated with lower treatment response to both antiviral agents used in the GLOBE trial; however the Caucasian patient population was very limited (n = 98).